Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1992;1(1):9–13. doi: 10.1155/S0962935192000036

Effect of hydrocortisone on interleukin-6 production in human ,peripheral blood rnononuclear ceils

Y Hirooka 1,✉, T Mitsuma 1, T Nogimori 2, Y Ishizukis 3
PMCID: PMC2365313  PMID: 18475434

Abstract

The effect of hydrocortisone on the production of interleukin-6 (IL-6) in human peripheral blood mononuclear cells was studied. Using our newly developed radioimmunoassay system for IL-6 of which specificity, reproducibility, sensitivity and usefulness have been demonstrated. IL-6 production in peripheral blood mononuclear cells of ten normal subjects revealed that in lipopolysaccharide (LPS, 10μg/ml)-stimulation, the mean ± SD of IL-6 was 2.71 ± 0.85 ng/ml. No detectable amount of IL-6 was observed in the absence of LPS and in the presence of hydrocortisone alone. Hydrocortisone (10−10 M to 10−3 M) inhibited LPS-stimulated IL-6 production in a dose-dependent manner. However, there was a wide variation in the response to hydrocortisone, namely, ranging from steroid-sensitive to steroid-resistant. Based on the concentration required to inhibit 50% of LPS-stimulated IL-6 production, three of ten subjects were at 10−6 M, three at 10−5 M and the rest at 10−4 M, respectively. The dramatic anti-inflammatory and immunosuppressive effects of glucocorticosteroids can be life-saving in autoimmune diseases. The present findings suggested that there existed the differences in susceptibility to glucocorticosteroids even among normal subjects, providing some implications for the drug treatment, and also gave further evidence that there may exist an immunoregulatory feedback circuit between the immune and neuroendocrine systems.

Full Text

The Full Text of this article is available as a PDF (400.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxter J. D., Harris A. W. Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression. Transplant Proc. 1975 Mar;7(1):55–65. [PubMed] [Google Scholar]
  2. Blalock J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989 Jan;69(1):1–32. doi: 10.1152/physrev.1989.69.1.1. [DOI] [PubMed] [Google Scholar]
  3. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  4. Dantzer R., Kelley K. W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 1989;44(26):1995–2008. doi: 10.1016/0024-3205(89)90345-7. [DOI] [PubMed] [Google Scholar]
  5. Hirooka Y., Ohtake K., Nogimori T., Mitsuma T. Impaired production of interleukin-2(IL2) in patients with Graves' disease by newly developed IL2 radioimmunoassay. Exp Clin Endocrinol. 1990 Sep;96(1):64–72. doi: 10.1055/s-0029-1210990. [DOI] [PubMed] [Google Scholar]
  6. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science. 1981 Jun 5;212(4499):1100–1109. doi: 10.1126/science.7233204. [DOI] [PubMed] [Google Scholar]
  7. Smith K. A., Crabtree G. R., Kennedy S. J., Munck A. U. Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes. Nature. 1977 Jun 9;267(5611):523–526. doi: 10.1038/267523a0. [DOI] [PubMed] [Google Scholar]
  8. Stein M., Schiavi R. C., Camerino M. Influence of brain and behavior on the immune system. Science. 1976 Feb 6;191(4226):435–440. doi: 10.1126/science.1108202. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES